Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Sigma Aldrich Fine Chemicals Biosciences Sphingosine 1-phosphate re

Catalog No. 502900952
Encompass

Sphingosine 1-phosphate (S1P) is a sphingolipid derived from ceramide by an enzymatic reaction in vivo.1 S1P acts as a signaling molecule by binding to G-protein coupled receptors (S1PR) (S1P1-5 receptors) which results in activation of small GTPases such as Ras Rac Rho and further downstream intracellular effects such as PI-3-Kinase Protein kinase C and Hippo signaling pathways. This generates an effect on cell migration differentiation and survival and therefore effects variety of systems such as immune system central nervous system and cardiovascular system.2 for instance S1P was found to inhibit cell apoptosis and induce cell proliferation by binding S1P1 to promote activation of ERK pathway.3 In addition S1P was found to support cancer cells by inducing angiogenesis and survival of proliferative cells in the tumor microenvironment.4 Due to the vast activities of S1P and the resulted S1PR irregular activation large discovery efforts are made to identify therapy by S1PR antag

Catalog No. 50-290-0952 Supplier Sigma Aldrich Fine Chemicals Biosciences Supplier No. SML27090.1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Sphingosine 1-phosphate (S1P) is a sphingolipid derived from ceramide by an enzymatic reaction in vivo.1 S1P acts as a signaling molecule by binding to G-protein coupled receptors (S1PR) (S1P1-5 receptors) which results in activation of small GTPases such as Ras Rac Rho and further downstream intracellular effects such as PI-3-Kinase Protein kinase C and Hippo signaling pathways. This generates an effect on cell migration differentiation and survival and therefore effects variety of systems such as immune system central nervous system and cardiovascular system.2 for instance S1P was found to inhibit cell apoptosis and induce cell proliferation by binding S1P1 to promote activation of ERK pathway.3 In addition S1P was found to support cancer cells by inducing angiogenesis and survival of proliferative cells in the tumor microenvironment.4 Due to the vast activities of S1P and the resulted S1PR irregular activation large discovery efforts are made to identify therapy by S1PR antag

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.